HORSHAM, Pa., Sept. 11, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Frank McCaney, President and Chief Executive Officer, will provide a corporate overview at the Rodman & Renshaw 19th Annual Global Investment Conference, being held September 11-12, 2017, in New York City.
Presentation Details:
Date: Tuesday, September 12
Time: 9:35am Eastern Time
Location: The Lotte New York Palace Hotel, The Louis Room
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystem, marketed specifically for the intended use of micropigmentation; and Nordlys, a multi-technology aesthetic laser device.
Investor Contacts:
| Christina L. Allgeier, Chief Financial Officer | Bob Yedid, Managing Director | |
| STRATA Skin Sciences, Inc. | LifeSci Advisors, LLC | |
| 215-619-3267 | 646-597-6989 | |
| [email protected] | [email protected] |


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Apple Turns 50: From Garage Startup to AI Crossroads
First Western Ship Transits Strait of Hormuz Since Iran War Began
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 



